Pharmaceutical
| Sun 29 Jun 2025
Alexandria, June 30 -- Janssen Pharmaceutica has applied United States patent for imidazopyridazine il-17 inhibitor compounds. Goldberg Steven D, Behenna Douglas C, Gordon Deane, Hanna Luke E, Loskot Steven A, Mccarver Stefan, Meduna Steven P, Shireman Brock T, Valdes Alexander E, Venable Jennifer D, Wu Dongpei and Xue Xiaohua d..